Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by MassMutual Private Wealth & Trust FSB

MassMutual Private Wealth & Trust FSB cut its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 13.9% during the fourth quarter, HoldingsChannel.com reports. The fund owned 988 shares of the medical equipment provider’s stock after selling 160 shares during the quarter. MassMutual Private Wealth & Trust FSB’s holdings in Intuitive Surgical were worth $516,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also recently bought and sold shares of the business. Godsey & Gibb Inc. grew its position in Intuitive Surgical by 140.0% in the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after buying an additional 35 shares during the last quarter. MidAtlantic Capital Management Inc. acquired a new stake in shares of Intuitive Surgical in the 3rd quarter valued at approximately $33,000. Decker Retirement Planning Inc. acquired a new stake in Intuitive Surgical in the fourth quarter valued at $36,000. Capital Performance Advisors LLP purchased a new stake in shares of Intuitive Surgical during the 3rd quarter worth $38,000. Finally, DT Investment Partners LLC increased its holdings in shares of Intuitive Surgical by 80.0% in the 3rd quarter. DT Investment Partners LLC now owns 81 shares of the medical equipment provider’s stock valued at $40,000 after purchasing an additional 36 shares in the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Stock Up 1.9 %

Shares of NASDAQ ISRG opened at $604.12 on Wednesday. The stock has a market capitalization of $215.18 billion, a PE ratio of 97.13, a P/E/G ratio of 5.04 and a beta of 1.39. The firm has a fifty day moving average of $541.80 and a 200-day moving average of $500.76. Intuitive Surgical, Inc. has a 52-week low of $362.14 and a 52-week high of $606.27.

Insider Buying and Selling at Intuitive Surgical

In other news, EVP Robert Desantis sold 1,012 shares of the business’s stock in a transaction dated Friday, October 25th. The stock was sold at an average price of $514.00, for a total transaction of $520,168.00. Following the completion of the sale, the executive vice president now owns 5,506 shares in the company, valued at approximately $2,830,084. The trade was a 15.53 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Jamie Samath sold 270 shares of the firm’s stock in a transaction that occurred on Tuesday, December 10th. The shares were sold at an average price of $540.15, for a total transaction of $145,840.50. Following the completion of the transaction, the chief financial officer now owns 8,757 shares in the company, valued at $4,730,093.55. The trade was a 2.99 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 43,509 shares of company stock valued at $22,602,212. Company insiders own 0.80% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages have weighed in on ISRG. Citigroup upped their target price on shares of Intuitive Surgical from $567.00 to $640.00 and gave the stock a “buy” rating in a research report on Wednesday, December 11th. The Goldman Sachs Group set a $604.00 price target on Intuitive Surgical in a report on Friday, October 18th. Morgan Stanley raised Intuitive Surgical from an “equal weight” rating to an “overweight” rating and lifted their price objective for the stock from $522.00 to $650.00 in a report on Monday, December 2nd. Royal Bank of Canada upped their target price on Intuitive Surgical from $525.00 to $555.00 and gave the company an “outperform” rating in a report on Friday, October 18th. Finally, Piper Sandler reaffirmed an “overweight” rating and set a $538.00 price target (up previously from $495.00) on shares of Intuitive Surgical in a research note on Friday, October 18th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have assigned a buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $554.17.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.